Induction Chemotherapy Followed by Immunotherapy Increases Pathological Complete Response Rate in dMMR/MSI-H Gastric ...
Introduction The mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H) gastric cancer (GC) constitutes a distinct molecular subtype, accounting for 8–22% of all cases.1,2 This subtype is characterized by a unique therapeutic profile: …